Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-68,939
Closed -$8.85M 67
2022
Q3
$8.85M Sell
68,939
-24,569
-26% -$3.55M 0.93% 41
2022
Q2
$13.2M Buy
93,508
+1,421
+2% +$203K 1.2% 17
2022
Q1
$12.8M Buy
92,087
+3,312
+4% +$508K 0.9% 47
2021
Q4
$15.5M Buy
88,775
+25,074
+39% +$4.18M 0.93% 43
2021
Q3
$10.6M Buy
63,701
+14,535
+30% +$2.5M 0.8% 55
2021
Q2
$8.85M Buy
49,166
+6,786
+16% +$1.24M 0.79% 64
2021
Q1
$8.17M Buy
42,380
+6,658
+19% +$1.28M 0.9% 47
2020
Q4
$7.21M Buy
+35,722
New +$7.39M 0.9% 40

Other funds holding CLX

2Xideas's CLX Position: Q4 2022 in Review

2Xideas sold out of Clorox (CLX) in Q4 2022, closing a stake of 68,939 shares — an estimated $8.85M sold.

2Xideas first reported a position in CLX in Q4 2020 and held it in 8 quarters. The position peaked at $15.5M in Q4 2021. 1,105 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • 2Xideas reported no remaining Clorox position as of Q4 2022 after selling out during the quarter.
  • 2Xideas sold 68,939 Clorox shares in Q4 2022, an estimated $8.85M.
  • 2Xideas first reported a position in Clorox in Q4 2020 and held it in 8 quarters.
  • 2Xideas's Clorox position peaked at $15.5M in Q4 2021.
  • 1,105 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on 2Xideas's 13F filing for Q4 2022, filed 14 Feb 2023.